Other adverse effects · patients with preventing morbidity and mortality in very preterm infants
1 finding from 1 review
Reported adverse effects · preterm infants
1 finding from 1 review
Hypercalcaemia · term breastfed infants to prevent vitamin D deficiency and improve bone health
Vitamin D given to lactating mothers showed no clear difference in adverse effects (hypercalcaemia) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Hypercalcaemia · term breastfed infants to prevent vitamin D deficiency and improve bone health
Vitamin D given to infants showed no clear difference in adverse effects (hypercalcaemia) compared with placebo or no treatment (low certainty).
1 finding from 1 review
Adverse effects related to intervention · preterm infants
1 finding from 1 review
Local adverse effects ‐ perioperative retinal haemorrhages (unit of analysis: eyes) · preterm infants with type 1 ROP
It is very uncertain whether anti‐vascular endothelial growth factor therapy combined with… changes local adverse effects ‐ perioperative retinal haemorrhages (unit of… compared with laser/cryotherapy (very low certainty).
1 finding from 1 review
Local adverse effects ‐ lens opacity requiring cataract removal (unit of analysis: eyes) · preterm infants with type 1 ROP
It is very uncertain whether anti‐vascular endothelial growth factor therapy changes local adverse effects ‐ lens opacity requiring cataract removal… compared with conventional laser/cryotherapy (very low certainty).
1 finding from 1 review
Local adverse effects ‐ corneal opacity requiring corneal transplant (unit of analysis: eyes) · preterm infants with type 1 ROP
It is very uncertain whether anti‐vascular endothelial growth factor therapy changes local adverse effects ‐ corneal opacity requiring corneal transplant… compared with conventional laser/cryotherapy (very low certainty).
1 finding from 1 review
Hypokalaemia · preterm infants (< 37 weeks GA) at risk of chronic lung disease
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse effects (short‐lasting skin reactions) · preterm infants
EMLA may leads to higher adverse effects (short‐lasting skin reactions) compared with placebo (low certainty).
1 finding from 1 review
Adverse effects (short‐lasting skin reactions) · preterm infants
1 finding from 1 review
Adverse effects: contact dermatitis · newborn infants with central venous catheters
Chlorhexidine dressing following alcohol cleansing probably leads to higher adverse effects: contact dermatitis compared with polyurethane dressing following aqueous povidone‐iodine cleansing (moderate certainty).
1 finding from 1 review
Adverse effects: contact dermatitis · newborn infants with central venous catheters
1 finding from 1 review
Intervention not reported
Adverse effects: fever 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: fever 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: vomiting 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: vomiting 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: diarrhoea 48 to 72 hours · infants 1 to 6 months of age
The intervention showed no clear difference in adverse effects: diarrhoea 48 to 72 hours (low certainty).
1 finding from 1 review
Intervention not reported
Adverse effects: bulging fontanelle within 48 to 72 hours · infants 1 to 6 months of age
The intervention leads to higher adverse effects: bulging fontanelle within 48 to 72 hours (high certainty).
1 finding from 1 review